alpha,beta-methyleneadenosine 5'-triphosphate has been researched along with n(6)-cyclopentyladenosine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armour, JA; Huang, MH; Pelleg, A; Sylvén, C | 1 |
| Starke, K; Stoffel, D; von Kügelgen, I | 1 |
| Capasso, A; Gallo, C | 1 |
| Inscho, EW; Osmond, DA | 1 |
4 other study(ies) available for alpha,beta-methyleneadenosine 5'-triphosphate and n(6)-cyclopentyladenosine
| Article | Year |
|---|---|
Responsiveness of in situ canine nodose ganglion afferent neurones to epicardial mechanical or chemical stimuli.
Topics: Adenosine; Adenosine Triphosphate; Animals; Bradykinin; Constriction; Coronary Vessels; Dogs; Female; Male; Mechanoreceptors; Neural Pathways; Neurons, Afferent; Nodose Ganglion; Pericardium; Substance P | 1994 |
P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Antihypertensive Agents; Atropine; Desipramine; Dose-Response Relationship, Drug; Electric Stimulation; Heart Atria; Indomethacin; Male; Norepinephrine; Phenethylamines; Protein Synthesis Inhibitors; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Receptors, Purinergic P2; Suramin; Triazines; Xanthines; Yohimbine | 1995 |
Functional interaction between purinergic system and opioid withdrawal: in vitro evidence.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Triphosphate; Analgesics, Opioid; Animals; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphine; Morphine Dependence; Muscle, Smooth; Naloxone; Narcotic Antagonists; Narcotics; Phenethylamines; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Quinidine; Receptor, Adenosine A1; Receptors, Adenosine A2; Receptors, Purinergic P2; Substance Withdrawal Syndrome; Theobromine; Theophylline | 2009 |
P2X(1) receptor blockade inhibits whole kidney autoregulation of renal blood flow in vivo.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine Triphosphate; Animals; Arterioles; Blood Pressure; Dinucleoside Phosphates; Dose-Response Relationship, Drug; Homeostasis; Kidney; Male; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, Purinergic P2; Receptors, Purinergic P2X; Renal Circulation; Xanthines | 2010 |